Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine vs Supportive Care in Elderly MDS Patients
NCT00043134Phase 3Unknown
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- May 2002
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 10
01
Overview
Phase 3, randomised, open-label trial of decitabine in myelodysplastic syndrome (MDS) and chronic myelomonocytic leukemia (CMML) (2 arms), sponsored by European Organisation for Research and Treatment of Cancer. Primary endpoint: Overall Survival. Status: unknown.
02
Drugs
decitabine
03
Conditions
myelodysplastic syndrome (MDS)chronic myelomonocytic leukemia (CMML)
Beyond the preview
Go deeper on NCT00043134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00043134.